Cerebral 1H MR spectroscopy and neuropsychologic status of patients with hepatic encephalopathy

American Journal of Roentgenology

Volumn 171, Issue 4, 1998, Pages 1123-1130

  Albert Thomas, M ^a   Huda, Amir ^a   Guze, Barry ^a,b   Curran, John ^a   Bugbee, Mary ^b   Fairbanks, Lynn ^b   Ke, Yong ^a   Oshiro, Thomas ^a   Martin, Paul ^b   Fawzy, Fawzy ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID; DIAGNOSTIC AGENT;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER TRANSPLANTATION; MALE; MOTOR PERFORMANCE; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROSCOPY; BRAIN; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADULT; BRAIN; CASE-CONTROL STUDIES; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 0032184838     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.171.4.9763008     Document Type: Article

References (38)

1. Fraser CL, Arieff AI. Hepatic encephalopathy. N Engl J Med 1985;313:865-873
2. Trzepacz PT, Levenson JL, Tringali RA. Psychopharmacology and neuropsychiatric syndromes in organ transplantation. Gen Hosp Psychiatry 1991; 13:233-245
3. Gitlin N. Hepatic encephalopathy. In: Zorkin D, Boyer TD, eds. Hepatology. Philadelphia: Saunders, 1996:605-617
4. Bernthal P, Hayes A, Tarter RE, et al. Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychologic test performance. Hepatology 1987;7:107-114
5. Zeneroli ML, Cioni G, Crisi G, Vezzelli C, Ventura E. Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: an MR imaging study. Magn Reson Imaging 1991;9:295-302
6. Inoue E, Hori S, Narumi Y, et al. Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 1991;179:551-555
7. Kulisevsky J, Pujol J, Balanzo J, et al. Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations. Hepatology 1992;16:1382-1388
8. Pujol A, Pujol J, Graus F, et al. Hyperintense globus pallidus on T1 weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 1993;43:65-69
9. 1 weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy. Hepatology 1995;21:440-442
10. Taylor-Robinson SD, Oatridge A, Hajnal JV, et al. MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetization transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab Brain Dis 1995;10:175-188
11. Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet 1995; 346:270-274
12. 31P nuclear magnetic resonance study. J Neurochem 1989;53:102-110
13. Chamuleau RA, Vogels BA, Bosnian DK, Bovaee WM. In vivo brain magnetic resonance imaging MRI and magnetic resonance spectroscopy MRS in hepatic encephalopathy. Adv Exp Med Biol 1994;368:23-31
14. 1H MR spectroscopy. Radiology 1992;182:9-27
15. Bottomley PA. Proton MR spectroscopy for diagnosing hepatic encephalopathy? Radiology 1992; 182:6-7
16. 1H NMR spectroscopy in patients with chronic hepatic encephalopathy: analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 1991;4:109-116
17. 1H MR spectroscopy: glutamate and glutamine, myo-inositol and related metabolites. NMR Biomed 1991;4:59-63
18. Ross BD, Jacobson S, Villamil F, et al. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994;193:457-463
19. Taylor-Robinson SD, Sargentoni J, Marcus CD, et al. Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 1994;9:347-359
20. Haussinger D, Laubenberger J, Vom Dahl S, et al. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994;107:1475-1480
21. Pujol J, Kulisevsky J, Moreno A, et al. Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy. Neurology 1996;41:1526-1530
22. Geissler A, Lock G, Frund R, et al. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 1997;25:48-54
23. Frahm J, Bruhn H, Gyngell ML, et al. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989;9:79-93
24. Moonen CTW, von Kienlin M, van Zijl PCM, et al. Comparison of single shot localization methods (STEAM and PRESS) for in vivo proton NMR spectra. NMR Biomed 1989;2:201-208
25. Pauly JM, Le Roux P, Nishimura D, Macovski A. Parameter relations for the Shinnar-Le Roux selective excitation pulse design algorithm. IEEE Trans Med Imaging 1991;10:53-65
26. Ryner LN, Ke Y, Thomas MA. Flip angle effects in STEAM and PRESS-optimized versus sine RF pulses. J Magn Reson 1998;131:118-125
27. Van Gorp WG, Satz P, Mitrushina M. Neuropsychological processes associated with normal aging. Dev Neuropsychol 1990;6:279-290
28. Albert MS, Heller HS, Milberg W. Changes in naming ability with age. Psychol Aging 1988;3:173-178
29. Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary. New York: Oxford Univ. Press, 1991
30. Heaton RK, Grant I, Matthews CG. Differences in neuropsychological test performance associated with age, education and sex. New York: Oxford Univ. Press, 1986
31. 0 field by post-processing. Magn Reson Med 1989;12:253-256
32. Klose U. In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med 1990;14:26-30
33. Krentz AJ, Dousset B, Mayer D, et al. Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients. Diabetes 1993;42:1753-1759
34. 1H NMR spectroscopy in vivo and in vitro. J Neurochem 1994;63: 1538-1543
35. Erer B, Polchi P, Lucarelli G, et al. CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors. Bone Marrow Transplant 1996;18:157-162
36. Serkova N, Christians U, Flogel U, et al. Assessment of the mechanisms of astrocyte swelling induced by the macrolide immunosuppressant sirolimus using multinuclear nuclear magnetic resonance spectroscopy. Chem Res Toxicol 1997;10:1359-1363;
37. Serkova N, Brand A, Christians U, Leibfritz D. Evaluation of the effects of immunosuppressants on neuronal and glial cells in vitro by multinuclear magnetic resonance spectroscopy. Biochim Biophys Acta 1996;1314:93-104
38. McCaffrey RJ, Westervelt HJ. Issues associated with repeated neuropsychological assessments. Neuropsychol Rev 1995;5:203-221